Mayersohn Joel David - Insider Non-Derivative Transactions at CITIUS ONCOLOGY, INC. (CTOR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Sep 19, 2025, Mayersohn Joel David's relationship to CITIUS ONCOLOGY, INC. (CTOR) is Director, and currently has 321,228 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CTOR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Mayersohn Joel David - Insider Non-Derivative Transactions of CTOR Common Stock

Mayersohn Joel David - Insider Non-Derivative Transactions at CTOR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Sep 20, 2025	Acquisition -- (Common Stock)	300000	0	321228
Jul 29, 2025	J -- (Common Stock)	21228	0	21228